Century Therapeutics, Inc. (IPSC) DCF Valuation

Century Therapeutics, Inc. (IPSC) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Century Therapeutics, Inc. (IPSC) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Whether you're an investor or analyst, this (IPSC) DCF Calculator is your go-to resource for accurate valuation. Featuring real data from Century Therapeutics, Inc., you can adjust forecasts and instantly observe the effects.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 5.2 2.2 1.9 1.6 1.4 1.2 1.0
Revenue Growth, % 0 0 0 0 -57.01 -14.25 -14.25 -14.25 -14.25 -14.25
EBITDA -19.8 -51.4 -89.9 -119.3 -121.2 .4 .3 .3 .2 .2
EBITDA, % 100 100 100 -2295.44 -5423.18 20 20 20 20 20
Depreciation .2 1.8 4.6 10.1 13.0 1.9 1.6 1.4 1.2 1.0
Depreciation, % 100 100 100 193.71 583.62 100 100 100 100 100
EBIT -20.0 -53.2 -94.5 -129.4 -134.3 .4 .3 .3 .2 .2
EBIT, % 100 100 100 -2489.15 -6006.8 20 20 20 20 20
Total Cash 81.5 75.8 222.9 315.5 172.7 1.9 1.6 1.4 1.2 1.0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .3 .8 .0
Account Receivables, % 100 100 100 15 0
Inventories 2.3 1.9 -.3 .0 .0 1.1 1.0 .8 .7 .6
Inventories, % 100 100 100 0 0 60 60 60 60 60
Accounts Payable 1.5 8.1 7.6 5.5 2.7 1.9 1.6 1.4 1.2 1.0
Accounts Payable, % 100 100 100 104.9 122.64 100 100 100 100 100
Capital Expenditure -2.5 -9.8 -45.0 -30.6 -13.7 -.8 -.7 -.6 -.5 -.4
Capital Expenditure, % 100 100 100 -588.65 -614.59 -40 -40 -40 -40 -40
Tax Rate, % -1.4 -1.4 -1.4 -1.4 -1.4 -1.4 -1.4 -1.4 -1.4 -1.4
EBITAT -20.1 -54.3 -94.5 -129.5 -136.1 .4 .3 .3 .2 .2
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -23.1 -55.4 -133.5 -153.0 -138.8 -1.6 1.4 1.2 1.0 .9
WACC, % 8.21 8.21 8.21 8.21 8.21 8.21 8.21 8.21 8.21 8.21
PV UFCF
SUM PV UFCF 1.9
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 1
Terminal Value 14
Present Terminal Value 10
Enterprise Value 12
Net Debt 1
Equity Value 11
Diluted Shares Outstanding, MM 59
Equity Value Per Share 0.18

What You Will Get

  • Editable Forecast Inputs: Effortlessly modify assumptions (growth %, margins, WACC) to explore various scenarios.
  • Real-World Data: Century Therapeutics, Inc. (IPSC) financial data pre-loaded to enhance your analysis.
  • Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
  • Customizable and Professional: A sleek Excel model tailored to meet your valuation requirements.
  • Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and optimizing your time.

Key Features

  • Customizable Research Parameters: Adjust essential factors such as clinical trial success rates, market penetration, and R&D expenses.
  • Instant Valuation Insights: Computes intrinsic value, net present value (NPV), and additional metrics in real-time.
  • High-Precision Accuracy: Incorporates Century Therapeutics' actual financial data for credible valuation results.
  • Streamlined Scenario Testing: Easily evaluate various assumptions and analyze different outcomes.
  • Efficiency Booster: Remove the hassle of creating intricate valuation models from the ground up.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review Century Therapeutics, Inc.'s (IPSC) pre-filled financial data and forecasts.
  3. Step 3: Modify critical inputs such as revenue growth, WACC, and tax rates (highlighted cells).
  4. Step 4: Watch the DCF model update instantly as you adjust your assumptions.
  5. Step 5: Analyze the outputs and leverage the results for your investment decisions.

Why Choose This Calculator for Century Therapeutics, Inc. (IPSC)?

  • Designed for Experts: A sophisticated tool utilized by researchers, financial analysts, and biotech consultants.
  • Accurate Data: Century Therapeutics’ historical and projected financials are preloaded for precision.
  • Scenario Analysis: Effortlessly explore various forecasts and assumptions.
  • Insightful Outputs: Automatically computes intrinsic value, NPV, and essential metrics.
  • User-Friendly: Comprehensive instructions lead you through each step of the process.

Who Should Use This Product?

  • Individual Investors: Gain insights to make informed decisions regarding Century Therapeutics, Inc. (IPSC) stock.
  • Financial Analysts: Enhance valuation processes with comprehensive financial models tailored for Century Therapeutics, Inc. (IPSC).
  • Consultants: Provide clients with accurate and timely valuation insights related to Century Therapeutics, Inc. (IPSC).
  • Business Owners: Learn from the valuation methods of innovative companies like Century Therapeutics, Inc. (IPSC) to inform your own business strategy.
  • Finance Students: Explore valuation techniques through the lens of real-world data and scenarios involving Century Therapeutics, Inc. (IPSC).

What the Template Contains

  • Historical Data: Includes Century Therapeutics, Inc.'s (IPSC) past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate Century Therapeutics, Inc.'s (IPSC) intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of Century Therapeutics, Inc.'s (IPSC) financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.

No products were found matching.